Commentary abstract


Nature Immunology 8, 329 - 331 (2007)
doi:10.1038/ni0407-329

Out of Africa: what can we learn from HIV-2 about protective immunity to HIV-1?

Sarah L Rowland-Jones1 & Hilton C Whittle1

  1. Sarah L. Rowland-Jones and Hilton C. Whittle are with the Medical Research Council Laboratories, Fajara, the Gambia, West Africa. e-mail: srowland-jones@mrc.gm


Most people infected with human immunodeficiency virus 2 (HIV-2) do not progress to disease, even though the minority who do cannot be distinguished clinically from HIV-1-infected patients. Here we review what is known about the basis of viral control in HIV-2 infection.

Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Dying T cells trigger autoimmunity in HIV

Nature Medicine News and Views (01 Dec 2007)

From Pan to pandemic

Nature News and Views (04 Feb 1999)

See all 9 matches for News And Views

Extra navigation

Subscribe to Nature Immunology

Subscribe

naturejobs

natureproducts


ADVERTISEMENT